The Latest Breaking News from Jazz

The Mavericks star left Sunday night’s season finale after getting injured in the third quarter.

Here’s what you need to know heading into the NBA postseason.

LOS ANGELES — The Los Angeles Lakers weren’t a sure thing; they were, though, the surest thing for bettors.

Rudy Gobert: There's a lot of teams and a lot of people that would love for us to to break apart. They would love to get a Rudy Gobert or Donovan Mitchell in their team and there's a lot of bigger markets who would love to get that and we…

The Utah Jazz (48-33) play against the Portland Trail Blazers (27-54) at Moda Center The Utah Jazz are spending $3,111,748 per win while the Portland Trail Blazers are spending $4,624,330 per win Game Time: 12:00 AM EDT on Sunday April 10, 2022 ...

Shams Charania: Center Greg Monroe will sign a deal with the Minnesota Timberwolves for the remainder of the season, sources tell @TheAthletic @Stadium. Monroe had productive stints in Minnesota, Washington, Utah and Milwaukee this season, ...

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired exclusive global development and commercialization rights to Werewolf Therapeutics Inc's (NASDAQ:HOWL) WTX-613. WTX-613 is a differentiated, conditionally-activated interferon-alpha (IFNα) INDUKINE molecule. "We believe WTX-613 has the potential to minimize the toxicity associated with systemic IFNα therapy, preferentially delivering IFNα to tumors, and thereby expanding its clinical utility in treating…

The Oklahoma City Thunder's two-game winning streak comes to an end with a 137-101 blowout loss via the Utah Jazz.

Over the past 3 months, 4 analysts have published their opinion on Jazz Pharmaceuticals (NASDAQ:JAZZ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.